Artigos de revistas sobre o tema "Disease progression score"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Disease progression score".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Shan, Guogen, Xinlin Lu, Zhigang Li, Jessica Z. K. Caldwell, Charles Bernick e Jeffrey Cummings. "ADSS: A Composite Score to Detect Disease Progression in Alzheimer’s Disease". Journal of Alzheimer's Disease Reports 8, n.º 1 (20 de fevereiro de 2024): 307–16. http://dx.doi.org/10.3233/adr-230043.
Texto completo da fonteRoussanov, Bisser V., Jeremy M. G. Taylor e Janis V. Giorgi. "Calculation and use of an HIV-1 disease progression score". AIDS 14, n.º 17 (dezembro de 2000): 2715–22. http://dx.doi.org/10.1097/00002030-200012010-00011.
Texto completo da fontePihlstrøm, Lasse, Kristina Rebekka Morset, Espen Grimstad, Valeria Vitelli e Mathias Toft. "A cumulative genetic risk score predicts progression in Parkinson's disease". Movement Disorders 31, n.º 4 (8 de fevereiro de 2016): 487–90. http://dx.doi.org/10.1002/mds.26505.
Texto completo da fonteUngaro, R., R. Jordan, C. Yzet, P. Bossuyt, F. Baert, T. Vanasek, G. R. D’Haens et al. "P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study". Journal of Crohn's and Colitis 14, Supplement_1 (janeiro de 2020): S264—S266. http://dx.doi.org/10.1093/ecco-jcc/jjz203.369.
Texto completo da fonteMoore, Ursula, Marni Jacobs, Meredith K. James, Anna G. Mayhew, Roberto Fernandez-Torron, Jia Feng, Avital Cnaan et al. "Assessment of disease progression in dysferlinopathy". Neurology 92, n.º 5 (9 de janeiro de 2019): e461-e474. http://dx.doi.org/10.1212/wnl.0000000000006858.
Texto completo da fonteShi, Manman, Yan Ouyang, Mingxin Yang, Meng Yang, Xiaoyan Zhang, Wei Huang, Weiming Wang et al. "IgA Nephropathy Susceptibility Loci and Disease Progression". Clinical Journal of the American Society of Nephrology 13, n.º 9 (24 de julho de 2018): 1330–38. http://dx.doi.org/10.2215/cjn.13701217.
Texto completo da fonteJönsson, Linus, Milana Ivkovic, Ron Handels, Anders Gustavsson, Teresa León, Julie Hviid Hahn-Pedersen e Lars Lau Raket. "OP142 Progression Analysis Versus Traditional Methods To Quantify Slowing Of Disease Progression In Alzheimer’s Disease". International Journal of Technology Assessment in Health Care 39, S1 (dezembro de 2023): S42. http://dx.doi.org/10.1017/s0266462323001435.
Texto completo da fonteViticchi, Giovanna, Lorenzo Falsetti, Laura Buratti, Cristiano Boria, Simona Luzzi, Marco Bartolini, Leandro Provinciali e Mauro Silvestrini. "Framingham risk score can predict cognitive decline progression in Alzheimer's disease". Neurobiology of Aging 36, n.º 11 (novembro de 2015): 2940–45. http://dx.doi.org/10.1016/j.neurobiolaging.2015.07.023.
Texto completo da fonteRavindran, J., C. Cavill, C. Balakrishnan, S. M. Jones, E. Korendowych e N. J. McHugh. "A modified sharp score demonstrates disease progression in established psoriatic arthritis". Arthritis Care & Research 62, n.º 1 (15 de janeiro de 2010): 86–91. http://dx.doi.org/10.1002/acr.20018.
Texto completo da fonteKataoka, Hiroshi, e Kazuma Sugie. "Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study". Neurology International 13, n.º 2 (26 de maio de 2021): 224–31. http://dx.doi.org/10.3390/neurolint13020023.
Texto completo da fontePreziosa, Paolo, Elisabetta Pagani, Alessandro Meani, Lucia Moiola, Mariaemma Rodegher, Massimo Filippi e Maria A. Rocca. "Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression". Neurology - Neuroimmunology Neuroinflammation 9, n.º 2 (1 de fevereiro de 2022): e1139. http://dx.doi.org/10.1212/nxi.0000000000001139.
Texto completo da fonteWang, Linbo, Wei Cheng, Edmund T. Rolls, Fuli Dai, Weikang Gong, Jingnan Du, Wei Zhang et al. "Association of specific biotypes in patients with Parkinson disease and disease progression". Neurology 95, n.º 11 (14 de agosto de 2020): e1445-e1460. http://dx.doi.org/10.1212/wnl.0000000000010498.
Texto completo da fonteSwanson, Gregory P., Steven Stone, Lauren Lenz e Todd Cohen. "Ability of cell-cycle progression score to predict risk for progression to metastatic disease and disease-specific mortality in prostate cancer patients after prostatectomy." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): 5524. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.5524.
Texto completo da fonteKoc, G. H., M. R. Kok, J. Luime, I. Tchetverikov, F. R. Kasiem, K. Wervers, Y. Goekoop-Ruiterman et al. "OP0065 THE DETERMINANTS OF RADIOGRAPHIC PROGRESSION IN EARLY PSA PATIENTS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 44.2–45. http://dx.doi.org/10.1136/annrheumdis-2023-eular.5638.
Texto completo da fonteMarkusse, Iris M., Linda Dirven, Marianne van den Broek, Casper Bijkerk, K. Huub Han, H. Karel Ronday, Rebecca Bolce et al. "A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study". Journal of Rheumatology 41, n.º 11 (15 de agosto de 2014): 2114–19. http://dx.doi.org/10.3899/jrheum.131412.
Texto completo da fonteLipshitz, Jay, Sewanti Limaye e Dilip Patel. "Leukocyte Alkaline Phosphatase Score as a Marker of Severity and Progression of Myelodysplastic Syndrome." Blood 110, n.º 11 (16 de novembro de 2007): 4625. http://dx.doi.org/10.1182/blood.v110.11.4625.4625.
Texto completo da fonteScelsi, Marzia A., Raiyan R. Khan, Marco Lorenzi, Leigh Christopher, Michael D. Greicius, Jonathan M. Schott, Sebastien Ourselin e Andre Altmann. "Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci". Brain 141, n.º 7 (30 de maio de 2018): 2167–80. http://dx.doi.org/10.1093/brain/awy141.
Texto completo da fonteEPSTEIN, JONATHAN I., CHARLES R. POUND, ALAN W. PARTIN e PATRICK C. WALSH. "DISEASE PROGRESSION FOLLOWING RADICAL PROSTATECTOMY IN MEN WITH GLEASON SCORE 7 TUMOR". Journal of Urology 160, n.º 1 (julho de 1998): 97–101. http://dx.doi.org/10.1016/s0022-5347(01)63045-3.
Texto completo da fonteRossetti, Heidi C., C. Munro Cullum, Linda S. Hynan e Laura H. Lacritz. "The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease". Alzheimer Disease & Associated Disorders 24, n.º 2 (abril de 2010): 138–42. http://dx.doi.org/10.1097/wad.0b013e3181b76415.
Texto completo da fonteMigliorelli, Carolina, Meritxell Gómez-Martinez, Paula Subías-Beltrán, Mireia Claramunt-Molet, Sebastian Idelsohn-Zielonka, Eudald Mas-Hurtado, Felip Miralles, Marisol Montolio, Marina Roselló-Ruano e Julita Medina-Cantillo. "Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy". Sensors 23, n.º 2 (11 de janeiro de 2023): 831. http://dx.doi.org/10.3390/s23020831.
Texto completo da fonteBergamaschi, Roberto, Silvana Quaglini, Eleonora Tavazzi, Maria Pia Amato, Damiano Paolicelli, Valentina Zipoli, Alfredo Romani et al. "Immunomodulatory therapies delay disease progression in multiple sclerosis". Multiple Sclerosis Journal 22, n.º 13 (20 de julho de 2016): 1732–40. http://dx.doi.org/10.1177/1352458512445941.
Texto completo da fonteHam, Young Rok, Eu Jin Lee, Hae Ri Kim, Jae Wan Jeon, Ki Ryang Na, Kang Wook Lee e Dae Eun Choi. "Ultrasound Renal Score to Predict the Renal Disease Prognosis in Patients with Diabetic Kidney Disease: An Investigative Study". Diagnostics 13, n.º 3 (31 de janeiro de 2023): 515. http://dx.doi.org/10.3390/diagnostics13030515.
Texto completo da fonteJehn, Lutz B., Ulrich Costabel, Eda Boerner, Julia Wälscher, Dirk Theegarten, Christian Taube e Francesco Bonella. "Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease". Journal of Clinical Medicine 12, n.º 3 (1 de fevereiro de 2023): 1173. http://dx.doi.org/10.3390/jcm12031173.
Texto completo da fonteKang, Min Kyoung, Jung Hwan Shin, Tae Jung Kim, Ji Sung Lee, Byung-Woo Yoon e Sang-Bae Ko. "Use of proton pump inhibitor may be associated with progression of cerebral small vessel disease". PLOS ONE 17, n.º 12 (21 de dezembro de 2022): e0279257. http://dx.doi.org/10.1371/journal.pone.0279257.
Texto completo da fontePavicic, Mirko, Kirk Overmyer, Attiq ur Rehman, Piet Jones, Daniel Jacobson e Kristiina Himanen. "Image-Based Methods to Score Fungal Pathogen Symptom Progression and Severity in Excised Arabidopsis Leaves". Plants 10, n.º 1 (15 de janeiro de 2021): 158. http://dx.doi.org/10.3390/plants10010158.
Texto completo da fonteChenniappan, Raghavi, Hanumanthappa Nandeesha, Shivanand Kattimani e Nandakumar Dalavaikodihalli Nanjaiah. "Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia". Annals of Neurosciences 27, n.º 1 (janeiro de 2020): 24–28. http://dx.doi.org/10.1177/0972753120929565.
Texto completo da fonteSegala, Francesco Vladimiro, Emanuele Rando, Federica Salvati, Marcantonio Negri, Francesca Catania, Flavia Sanmartin, Rita Murri, Evangelos J. Giamarellos-Bourboulis e Massimo Fantoni. "Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: A real world, retrospective cohort study". PLOS ONE 18, n.º 4 (4 de abril de 2023): e0273202. http://dx.doi.org/10.1371/journal.pone.0273202.
Texto completo da fonteUmemoto, George, Shinsuke Fujioka, Yasuyuki Iwasa, Yoshie Ozaki, Kayoko Koga, Kazumi Nishimura e Yoshio Tsuboi. "Impact of Progression of Parkinson’s Disease on Swallowing Ability and Oral Environment". Parkinson's Disease 2021 (23 de abril de 2021): 1–6. http://dx.doi.org/10.1155/2021/5571556.
Texto completo da fonteXie, Linjun, Keke Hou, Huayan Xu, Hang Fu, Rong Xu, Hui Liu, Zhongqin Zhou, Zhenlin Li, Ming Yang e Yingkun Guo. "Chest CT features and progression of patients with coronavirus disease 2019". British Journal of Radiology 93, n.º 1116 (1 de dezembro de 2020): 20200219. http://dx.doi.org/10.1259/bjr.20200219.
Texto completo da fonteTsai, Tsung-Ying, Pai-Feng Hsu, Cheng-Hsueh Wu, Shao-Sung Huang, Wan-Leong Chan, Shing-Jong Lin, Jaw-Wen Chen, Tse-Min Lu e Hsin-Bang Leu. "Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores". Nutrients 14, n.º 15 (30 de julho de 2022): 3163. http://dx.doi.org/10.3390/nu14153163.
Texto completo da fonteChen, Szu-Ju, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang e Chin-Hsien Lin. "Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease". Journal of Parkinson's Disease 11, n.º 3 (2 de agosto de 2021): 1129–39. http://dx.doi.org/10.3233/jpd-212574.
Texto completo da fonteJedynak, Bruno M., Andrew Lang, Bo Liu, Elyse Katz, Yanwei Zhang, Bradley T. Wyman, David Raunig, C. Pierre Jedynak, Brian Caffo e Jerry L. Prince. "A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort". NeuroImage 63, n.º 3 (novembro de 2012): 1478–86. http://dx.doi.org/10.1016/j.neuroimage.2012.07.059.
Texto completo da fonteYavuz, Yasemin. "Are the Beck depression inventory score, SF 36 score and progression of the disease changing with education in chronic kidney disease patients?" Annals of Medical Research 25, n.º 4 (2018): 723. http://dx.doi.org/10.5455/annalsmedres.2018.05.091.
Texto completo da fonteYang, Yongbo, Jian Wang, Qun Liang, Yi Wang, Xinhua Chen, Qingrong Zhang, Shijie Na et al. "PHACTR1 is associated with disease progression in Chinese Moyamoya disease". PeerJ 8 (5 de maio de 2020): e8841. http://dx.doi.org/10.7717/peerj.8841.
Texto completo da fonteOefelein, Michael G. "RE: DISEASE PROGRESSION FOLLOWING RADICAL PROSTATECTOMY IN MEN WITH GLEASON SCORE 7 TUMOR". Journal of Urology 161, n.º 1 (janeiro de 1999): 231. http://dx.doi.org/10.1016/s0022-5347(01)62114-1.
Texto completo da fonteSerednicka, K., A. E. Smyth, C. M. Black e C. P. Denton. "Using a self-reported functional score to assess disease progression in systemic sclerosis". Rheumatology 46, n.º 7 (9 de maio de 2007): 1107–10. http://dx.doi.org/10.1093/rheumatology/kel432.
Texto completo da fonteHarrison, Madaline B., Scott A. Wylie, Robert C. Frysinger, James T. Patrie, Diane S. Huss, Lillian J. Currie e G. Frederick Wooten. "UPDRS activity of daily living score as a marker of Parkinson's disease progression". Movement Disorders 24, n.º 2 (30 de janeiro de 2009): 224–30. http://dx.doi.org/10.1002/mds.22335.
Texto completo da fonteRodríguez-Rodríguez, E., P. Sánchez-Juan, J. L. Vázquez-Higuera, I. Mateo, A. Pozueta, J. Berciano, S. Cervantes et al. "Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease". Journal of Neural Transmission 120, n.º 5 (20 de novembro de 2012): 807–12. http://dx.doi.org/10.1007/s00702-012-0920-x.
Texto completo da fonteGao, Yang, Hong-Liang Zhang, Meiying Xin, Dong Wang, Nannan Zheng, Shuang Wang, Jiancheng Xu, Ying Wang, Jie Zhu e Jiachun Feng. "Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression". BioMed Research International 2018 (14 de junho de 2018): 1–5. http://dx.doi.org/10.1155/2018/5703279.
Texto completo da fonteRossi, Silvia, Fabio Buttari, Valeria Studer, Caterina Motta, Paolo Gravina, Maura Castelli, Vilma Mantovani et al. "The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis". Multiple Sclerosis Journal 17, n.º 3 (8 de dezembro de 2010): 281–88. http://dx.doi.org/10.1177/1352458510388680.
Texto completo da fonteHasimoglu, Yasemin G., Xiqun Chen, Rachit Bakshi, Michael A. Schwarzschild e Eric A. Macklin. "Does Serum Urate Change as Parkinson’s Disease Progresses?" Journal of Parkinson's Disease 10, n.º 4 (27 de outubro de 2020): 1571–76. http://dx.doi.org/10.3233/jpd-202064.
Texto completo da fonteStopsack, Konrad H., Charles A. Whittaker, Travis A. Gerke, Massimo Loda, Philip W. Kantoff, Lorelei A. Mucci e Angelika Amon. "Aneuploidy drives lethal progression in prostate cancer". Proceedings of the National Academy of Sciences 116, n.º 23 (13 de maio de 2019): 11390–95. http://dx.doi.org/10.1073/pnas.1902645116.
Texto completo da fonteSharad, Shashwat, Zsã³fia Sztupinszki, Zoltan Szallasi, Inger L. Rosner, Shiv Srivastava, Albert Dobi, Jennifer Cullen e Hua Li. "PMEPA1 gene isoforms to indicate disease progression in solid tumors." Journal of Clinical Oncology 37, n.º 15_suppl (20 de maio de 2019): e16580-e16580. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e16580.
Texto completo da fonteKister, Ilya, e Orhun H. Kantarci. "Multiple Sclerosis Severity Score: Concept and applications". Multiple Sclerosis Journal 26, n.º 5 (22 de janeiro de 2020): 548–53. http://dx.doi.org/10.1177/1352458519880125.
Texto completo da fonteGautam, Sachin, Rahul Kumar, Dharam Pal Bhadoria, Govind Mawari, Naresh Kumar, Mradul K. Daga, Sanjay Pandit et al. "Clinical profile of hospitalised moderate category COVID-19 patients: Short study from a Tertiary Care Centre in Delhi". Journal of Family Medicine and Primary Care 12, n.º 8 (agosto de 2023): 1644–53. http://dx.doi.org/10.4103/jfmpc.jfmpc_2245_22.
Texto completo da fonteMills, James A., Jeffrey D. Long, Amrita Mohan, Jennifer J. Ware e Cristina Sampaio. "Cognitive and Motor Norms for Huntington’s Disease". Archives of Clinical Neuropsychology 35, n.º 6 (14 de maio de 2020): 671–82. http://dx.doi.org/10.1093/arclin/acaa026.
Texto completo da fonteBrandt, L., H. Schulze-Koops, T. Hügle, M. J. Nissen, H. Paul e R. Muller. "OP0185 RADIOGRAPHIC PROGRESSION DESPITE PERSISTENT LDA OR REMISSION IS INFLUENCED BY CURRENT SMOKING RATHER THAN THE RESPECTIVE DAS 28 LEVEL, RESULTS OF THE SWISS RHEUMATOID ARTHRITIS REGISTER (SCQM)". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de maio de 2021): 112.1–112. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2557.
Texto completo da fonteClancy, Una, Stephen D. J. Makin, Caroline A. McHutchison, Vera Cvoro, Francesca M. Chappell, Maria del C. Valdés Hernández, Eleni Sakka, Fergus Doubal e Joanna M. Wardlaw. "Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke". Neurology 98, n.º 14 (7 de fevereiro de 2022): e1459-e1469. http://dx.doi.org/10.1212/wnl.0000000000200005.
Texto completo da fonteMello, Ricardo Andrade Fernandes de, Melissa Bosi Nonato Mello, Laís Bastos Pessanha e Ana Paula Alves Fonseca. "Skeletal involvement in Gaucher disease: extent of bone disease, splenic volume, and quality of life". Radiologia Brasileira 54, n.º 2 (abril de 2021): 71–76. http://dx.doi.org/10.1590/0100-3984.2020.0014.
Texto completo da fonteJedynak, Bruno, Zhou Ye, Andrew Lang, Runze Tang, Pierre Jedynak e Jerry Prince. "P1-197: The Alzheimer's Disease Progression Score (ADPS) can predict the transition from MCI to Alzheimer's disease". Alzheimer's & Dementia 9 (julho de 2013): P223. http://dx.doi.org/10.1016/j.jalz.2013.05.420.
Texto completo da fonte